UniProtKB/Swiss-Prot Q9NS18: Variant p.Lys95Glu

Glutaredoxin-2, mitochondrial
Gene: GLRX2
Feedback?

Variant information Variant position:

95 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Lysine (K) to Glutamate (E) at position 95 (K95E, p.Lys95Glu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (K) to medium size and acidic (E) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs34237236 [ dbSNP | Ensembl ]

Sequence information Variant position:

95 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

164 The length of the canonical sequence.
Location on the sequence:

TSCSYCTMAKKLFHDMNVNY K VVELDLLEYGNQFQDALYKM The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         TSCSYCTMA-KKLFHDMNVNYK---VVELDLLEYGNQFQDALYKM

Mouse                         TSCSYCSMA-KKIFHDMNVNYK---AVELDMLEYGNQFQDA

Rat                           SSCSYCSMA-KKIFHDMNVNYK---VVELDMVEYGSQFQEA

Bovine                        TSCSYCTMA-KNLFHDMNVNYK---VVELDMLEYGSQFQDA

Baker's yeast                 TYCPYCKATLSTLFQELNVPKSKALVLELDEMSNGSEIQDA

Fission yeast                 SFCPFCKAA-KNTLTKYSAPYK---AYELDKIENGSDIQAY

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	20 – 164	Glutaredoxin-2, mitochondrial
Domain	57 – 157	Glutaredoxin
Binding site	109 – 109
Modified residue	77 – 77	S-glutathionyl cysteine; alternate
Mutagenesis	78 – 78	S -> P. Specifically increases the specific activity but decreases affinity for glutathionylated substrates.
Mutagenesis	80 – 80	C -> S. Strongly impairs enzymatic activity.
Beta strand	95 – 98

Literature citations
Submission
NIEHS SNPs program;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANT GLU-95;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.